Affordable Inhalers and Nebulizers Act of 2025 reduces cost-sharing for inhalers treating asthma and COPD.
The Affordable Inhalers and Nebulizers Act of 2025 amends the Public Health Service Act, the Internal Revenue Code, and the Employee Retirement Income Security Act of 1974 to reduce patient cost-sharing for prescription drug inhaler products used to treat breathing disorders such as asthma and chronic obstructive pulmonary disease. It mandates that group health plans and health insurance issuers offering group or individual health insurance coverage provide benefits for all specified inhaler products without applying any deductible or imposing any cost-sharing requirement exceeding $15 per.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.